Position in APGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$757,530
-$450,150 QoQ
Shares Held
9,000
-43.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLDB |
Solid Biosciences Inc.
|
666,196 | $6,655,298 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
385,900 | $6,529,428 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
178,110 | $5,827,759 | |
| 4 | NKTR |
Nektar Therapeutics
|
81,000 | $5,654,610 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
57,200 | $4,973,540 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
449,019 | $4,395,896 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
171,000 | $4,326,300 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
35,018 | $4,292,506 |
All Filings in APGE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $757,530 | 9,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,207,680 | 16,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $635,680 | 16,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $694,880 | 16,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $298,880 | 8,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||